Novavax signs licensing agreement with Pfizer for vaccine development

Go back to Novavax signs licensing agreement with Pfizer for vaccine development
Novavax, Inc. (NASDAQ: NVAX) Delayed: 12.75 +1.74 (15.80%)
Previous Close $11.01    52 Week High $9.23 
Open $11.17    52 Week Low $1.16 
Day High $13.04    P/E N/A 
Day Low $11.03    EPS $-0.30 
Volume 18,991,169